Gabriela Ispas Selected Research

Length of Stay

1/2022	Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study.
11/2021	Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza-Related Hospitalizations in Adults-A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriela Ispas Research Topics

Disease

3	Human Influenza (Influenza) 01/2022 - 12/2014
2	Infections 01/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

2	Oxygen (Dioxygen)IBA 01/2022 - 11/2021
2	Antiviral Agents (Antivirals)IBA 12/2014 - 01/2013
1	SteroidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Antitussive Agents (Antitussives)FDA Link 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	2- (6- ((2- (3- hydroxypropyl)- 5- methylphenylamino)methyl)- 2- (3- morpholin- 4- ylpropylamino)benzoimidazol- 1- ylmethyl)- 6- methylpyridin- 3- olIBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 12/2014

Therapy/Procedure

2	Length of Stay 01/2022 - 11/2021
1	Patient Readmission 01/2022